既往剖宫产女性孕11-14周经阴道超声早期预测胎盘植入谱系疾病
该回顾性队列纳入467例有剖宫产史女性,在孕11-14周行经阴道超声并按胎盘与瘢痕位置分级。8例(1.7%)分娩时组织学确诊胎盘植入谱系疾病。瘢痕龛内胎盘植入(2级)预测特异性100%、阳性预测值100%,任何超声怀疑(1或2级)敏感性75%、阴性预测值99.6%。
要点
- 孕11-14周经阴道超声可识别至少3/4的胎盘植入谱系疾病病例。
- 胎盘植入瘢痕龛内(2级)阳性预测值达100%,特异性100%。
- 任何超声怀疑(1或2级)阴性预测值99.6%,特异性95.9%。
核心结论
- 既往剖宫产女性孕11-14周经阴道超声可识别至少3/4的胎盘植入谱系疾病病例。
- 胎盘植入瘢痕龛内对胎盘植入谱系疾病有高阳性预测值。
研究设计与样本
- 回顾性队列研究,纳入2016年9月至2018年5月间有剖宫产史且在孕11-14周行经阴道超声的女性467例。
- 按胎盘与瘢痕位置分级:0级无怀疑、1级中间怀疑(胎盘毗邻或位于瘢痕上)、2级高度怀疑(胎盘位于瘢痕龛内)。
- 所有图像由对结局盲法的 trained specialists 复核并分级。
- 主要结局为分娩时胎盘植入谱系疾病的组织学诊断。
主要发现
- 467例中8例(1.7%)分娩时有胎盘植入谱系疾病。
- 原始报告分级:442例(94.6%)为0级,20例(4.3%)为1级,5例(1.1%)为2级。
- 复核分级:456例(97.6%)为0级,5例(1.1%)为1级,6例(1.3%)为2级。
- 2级患者敏感性62.5%(95%CI 24.5-91.5),特异性100%(95%CI 99.2-100.0),阳性预测值100%(95%CI 97.0-100.0),阴性预测值99.4%(95%CI 98.4-99.7)。
- 任何超声怀疑(1或2级)敏感性75%(95%CI 34.9-96.8),特异性95.9%(95%CI 93.6-97.5),阳性预测值24%(95%CI 14.8-36.4),阴性预测值99.6%(95%CI 98.5-99.9)。
关键数值与推荐
- 分级标准:0级为胎盘不毗邻瘢痕;1级为胎盘毗邻或位于瘢痕上;2级为胎盘位于瘢痕龛内。
临床怎么用
- 对既往剖宫产女性可在孕11-14周经阴道超声评估胎盘与瘢痕位置以早期识别胎盘植入谱系疾病高风险者。
- 发现胎盘位于瘢痕龛内时阳性预测值高,应加强后续监测与管理。
- 超声未见怀疑时阴性预测值高,但仍需按常规产检随访。
局限性
- 本研究为回顾性队列,需前瞻性研究评估既往剖宫产女性孕11-14周常规筛查胎盘植入谱系疾病的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a growing body of evidence that sonographic signs of placenta accreta spectrum can be observed in the first trimester of pregnancy. The most significant marker is placental location next to or in the scar niche in women with a prior cesarean delivery. OBJECTIVE: This study aimed to assess the performance of transvaginal ultrasound in the early prediction of placenta accreta spectrum in women with a prior cesarean delivery. STUDY DESIGN: This was a retrospective cohort of women with a history of cesarean delivery who had transvaginal ultrasound at 11 to 14 weeks' gestation between September 2016 and May 2018. Ultrasound reports were reviewed and graded for suspicion of placenta accreta spectrum as follows: Grade 0 (no suspicion) if the placenta is not next to the scar; Grade 1 (intermediate suspicion) if the placenta is next or on the scar; Grade 2 (high suspicion) if the placenta was inside the scar niche. In addition, all images were reviewed and graded by trained specialists blinded to the outcome. The primary outcome was a histologic diagnosis of placenta accreta spectrum. Sensitivity, specificity, positive predictive value, and negative predictive value of first-trimester transvaginal ultrasound to detect placenta accreta spectrum were assessed. RESULTS: In this study, 467 patients were included, and 8 (1.7%) had placenta accreta spectrum at delivery. Using the original report, 442 patients (94.6%) were Grade 0, 20 (4.3%) Grade 1, and 5 (1.1%) Grade 2. The revised grading had 456 patients (97.6%) with Grade 0, 5 (1.1%) with Grade 1, and 6 (1.3%) with Grade 2. Patients with Grade 2 yielded a sensitivity of 62.5% (95% confidence interval, 24.5-91.5), specificity of 100% (95% confidence interval, 99.2-100.0), positive predictive value of 100% (95% confidence interval, 97.0-100.0), and negative predictive value of 99.4% (95% confidence interval, 98.4-99.7). Any sonographic suspicion of placenta accreta spectrum (Grade 1 or Grade 2) had a sensitivity of 75% (95% confidence interval, 34.9-96.8), specificity of 95.9% (95% confidence interval, 93.6-97.5), positive predictive value of 24% (95% confidence interval, 14.8-36.4), and negative predictive value of 99.6% (95% confidence interval, 98.5-99.9). The blinded image review yielded a better specificity (99.1% vs 95.9%; P=.001) and a positive predictive value (63.6% vs 24%; P=.02) with similar sensitivity (87.5% vs 75%; P=.52) and negative predictive value (99.8% vs 99.6%; P=.55). CONCLUSION: Transvaginal ultrasound between 11 and 14 weeks' gestation in women a with prior cesarean delivery can identify at least 3 of 4 cases of placenta accreta spectrum. A finding of placental implantation within the scar niche has high positive predictive value for placenta accreta spectrum. Prospective studies are needed to assess routine screening for placenta accreta spectrum at 11 to 14 weeks' gestation in women with a prior cesarean delivery.
引用
- Doulaveris G, Ryken K, Papathomas D, et al. Early prediction of placenta accreta spectrum in women with prior cesarean delivery using transvaginal ultrasound at 11 to 14 weeks. Am J Obstet Gynecol MFM. 2020. PMID: 33345909. doi:10.1016/j.ajogmf.2020.100183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。